Genotypic Changes in Human Immunodeficiency Virus Type 1 Protease Associated with Reduced Susceptibility and Virologic Response to the Protease Inhibitor Tipranavir von BAXTER, John D, SCHAPIRO, Jonathan M, BOUCHER, Charles A. B, KOHLBRENNER, Veronika M, HALL, David B, SCHERER, Joseph R, MAYERS, Douglas L

Volltext

Efficacy and safety of three doses of tipranavir boosted with ritonavir in treatment-experienced HIV type 1-infected patients von GATHE, Joseph C, PIERONE, Gerald, SABO, John, MAYERS, Douglas, PILIERO, Peter, ARASTEH, Keikawus, RUBIO, Rafael, LALONDE, Richard G, COOPER, David, LAZZARIN, Adriano, KOHLBRENNER, Veronika M, DOHNANYI, Catherine

Volltext

Seeking ethical designs for HIV clinical trials in treatment-experienced patients : An industry perspective von MAYERS, Douglas L, CHUNG, Jain, KOHLBRENNER, Veronika M, HALL, David B, DEMASI, Ralph A, NEUBACHER, Dietmar, BUSS, Neil E, SALGO, Miklos P

Volltext

Cefixime vs. cefaclor in the treatment of acute otitis media in children: a randomized, comparative study von RODRIGUEZ, WILLIAM J, KHAN, WAHEED, SAIT, TAHIR, CHHABRA, OM P, BELL, THOMAS A, AKRAM, SHAMA, KOHLBRENNER, VERONIKA M

Volltext

Efficacy and Safety of Three Doses of Tipranavir Boosted with Ritonavir in Treatment-Experienced HIV Type 1-Infected Patients von Gathe, Joseph C., Pierone, Gerald, Piliero, Peter, Arasteh, Keikawus, Rubio, Rafael, Lalonde, Richard G., Cooper, David, Lazzarin, Adriano, Kohlbrenner, Veronika M., Dohnanyi, Catherine, Sabo, John, Mayers, Douglas

Volltext

Once-A-Day therapy for sinusitis: A comparison study of cefixime and amoxicillin von Edelstein, David R., Avner, Sanford E., Chow, James M., Duerksen, Roger L., Johnson, Jonas, Ronis, Max, Rybak, Leonard P., Bierman, Warren C., Matthews, Brian L., Kohlbrenner, Veronika M.

Volltext

Evaluation of cefixime in the treatment of bacterial maxillary sinusitis von Matthews, B L, Kohut, R I, Edelstein, D R, Rybak, L P, Rapp, M, McCaffrey, T V, Kimmelman, C P, Parnes, S M, Marinaccio, A T, Kohlbrenner, V M

Volltext

Disease frequency, patient characteristics, comorbidity outcomes and immunosuppressive therapy in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: a... von Li, Qiang, Wallace, Laura, Patnaik, Padmaja, Alves, Margarida, Gahlemann, Martina, Kohlbrenner, Veronika, Raabe, Christina, Wang, Jocelyn R, Garry, Elizabeth M

Volltext

Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Global Pharmacovigilance Data von Lasky, Joseph A., Criner, Gerard J., Lazarus, Howard M., Kohlbrenner, Veronika, Bender, Shaun, Richeldi, Luca

Volltext

Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial von Seibold, James R, Maher, Toby M, Highland, Kristin B, Assassi, Shervin, Azuma, Arata, Hummers, Laura Kathleen, Costabel, Ulrich, von Wangenheim, Ute, Kohlbrenner, Veronika, Gahlemann, Martina, Alves, Margarida, Distler, Oliver, SENSCIS trial investigators

Volltext

Safety of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis: Global Pharmacovigilance Data von Lasky, Joseph A., Criner, Gerard J., Lazarus, Howard M., Kohlbrenner, Veronika, Bender, Shaun, Richeldi, Luca

Volltext bestellen